Indefinite Delivery Contract 75N93024D00005
Active Awarded Last action
- Contract number
- 75N93024D00005
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $1,250,576 obligated
Award facts
- Opportunity
-
- Pre-Clinical Models of Infectious Diseases Pre-Solicitation · NIHAI75N93023R00003 · Posted Oct 21, 2022
- Combined order value
-
- $1,250,576 Current, with exercised options
- $4,824,313 Potential, with all options
- Last date to order 33% complete
- IDV ceiling 1% used
- $146,300,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 76 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Battelle Memorial Institute on July 15, 2024, with a ceiling of $146.3 million and an ultimate completion date of July 14, 2031. This is a single-award contract with no set-aside.
Work is performed in Columbus, Ohio. The contract supports preclinical drug candidate evaluation, animal model development, and infectious disease research, including evaluation of antiviral drug candidates against mpox in nonhuman primates and ferret model refinement for improved influenza vaccines.
The originating solicitation was posted on October 21, 2022, with a due date of November 7, 2022. The period of performance runs through July 14, 2031.
Recent task-order activity includes Task Order B03, issued September 30, 2025, for $4.824 million to evaluate antiviral drug candidates against mpox in nonhuman primates, extending through April 30, 2027, performed in Columbus, Ohio under cost-plus-fixed-fee pricing.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pcmid task order B03 - evaluation of antiviral drug candidates against mpox in nhps | National Institute of Allergy and Infectious Diseases (NIH) | $1,250,576 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93024D00005?
75N93024D00005 was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2024.
How much is contract 75N93024D00005 worth?
Orders under 75N93024D00005 have obligated $1,250,576. Their combined potential value, with all options, is $4,824,313. 75N93024D00005's own ceiling is $146,300,000.
How many orders have been placed under contract 75N93024D00005?
1 order has been placed under 75N93024D00005, the latest on September 30, 2025.
Who can order from contract 75N93024D00005?
75N93024D00005 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93024D00005 part of a contract vehicle?
Yes. 75N93024D00005 is part of Pre-Clinical Models of Infectious Diseases.
Was contract 75N93024D00005 competed?
The extent of competition for 75N93024D00005 was full and open competition. The government received 76 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV